Global Plasma Derived Therapies Market Research Report 2025(Status and Outlook)
Plasma derived therapies are a specialized class of biologic medicines derived from human plasma, primarily used to treat rare, chronic, and often life-threatening conditions caused by deficiencies or dysfunctions in plasma proteins. These therapies include immunoglobulins (for immune deficiencies and autoimmune disorders), albumin (for hypovolemia and burns), clotting factors (such as Factor VIII and IX for hemophilia), and alpha-1 antitrypsin (for genetic emphysema), among others. The production process involves large-scale plasma collection through donation, rigorous screening and testing for pathogens, followed by fractionation and purification to isolate specific proteins, ensuring both therapeutic efficacy and safety. These products are indispensable in clinical settings due to their targeted mechanism of action and the lack of alternatives for many of the conditions they address.
The global Plasma Derived Therapies market size was estimated at USD 22150.0 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 7.55% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Plasma Derived Therapies market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Plasma Derived Therapies market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Plasma Derived Therapies market.
Global Plasma Derived Therapies Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
CSL Behring LLC
Shire
Bayer
Kedrion
Takeda
Biotest
Octaparma
Bio Products Laboratory (BPL)
LFB
Grifols
Market Segmentation (by Type)
Albumin
Immunoglobulin
Factor VIII
Others
Market Segmentation (by Application)
Hemophilia
Primary Immunodeficiencies (PIDs)
Idiopathic Thrombocytopenic Purpura (ITP)
COVID-19
Others
Geographic Segmentation
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Plasma Derived Therapies Market
Overview of the regional outlook of the Plasma Derived Therapies Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Plasma Derived Therapies Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Plasma Derived Therapies, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Plasma Derived Therapies market size was estimated at USD 22150.0 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 7.55% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Plasma Derived Therapies market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Plasma Derived Therapies market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Plasma Derived Therapies market.
Global Plasma Derived Therapies Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
CSL Behring LLC
Shire
Bayer
Kedrion
Takeda
Biotest
Octaparma
Bio Products Laboratory (BPL)
LFB
Grifols
Market Segmentation (by Type)
Albumin
Immunoglobulin
Factor VIII
Others
Market Segmentation (by Application)
Hemophilia
Primary Immunodeficiencies (PIDs)
Idiopathic Thrombocytopenic Purpura (ITP)
COVID-19
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Plasma Derived Therapies Market
Overview of the regional outlook of the Plasma Derived Therapies Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Plasma Derived Therapies Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Plasma Derived Therapies, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Plasma Derived Therapies
1.2 Key Market Segments
1.2.1 Plasma Derived Therapies Segment by Type
1.2.2 Plasma Derived Therapies Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PLASMA DERIVED THERAPIES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Plasma Derived Therapies Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Plasma Derived Therapies Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PLASMA DERIVED THERAPIES MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Plasma Derived Therapies Product Life Cycle
3.3 Global Plasma Derived Therapies Sales by Manufacturers (2020-2025)
3.4 Global Plasma Derived Therapies Revenue Market Share by Manufacturers (2020-2025)
3.5 Plasma Derived Therapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Plasma Derived Therapies Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Plasma Derived Therapies Market Competitive Situation and Trends
3.8.1 Plasma Derived Therapies Market Concentration Rate
3.8.2 Global 5 and 10 Largest Plasma Derived Therapies Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 PLASMA DERIVED THERAPIES INDUSTRY CHAIN ANALYSIS
4.1 Plasma Derived Therapies Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PLASMA DERIVED THERAPIES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Plasma Derived Therapies Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Plasma Derived Therapies Market
5.7 ESG Ratings of Leading Companies
6 PLASMA DERIVED THERAPIES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Plasma Derived Therapies Sales Market Share by Type (2020-2025)
6.3 Global Plasma Derived Therapies Market Size Market Share by Type (2020-2025)
6.4 Global Plasma Derived Therapies Price by Type (2020-2025)
7 PLASMA DERIVED THERAPIES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Plasma Derived Therapies Market Sales by Application (2020-2025)
7.3 Global Plasma Derived Therapies Market Size (M USD) by Application (2020-2025)
7.4 Global Plasma Derived Therapies Sales Growth Rate by Application (2020-2025)
8 PLASMA DERIVED THERAPIES MARKET SALES BY REGION
8.1 Global Plasma Derived Therapies Sales by Region
8.1.1 Global Plasma Derived Therapies Sales by Region
8.1.2 Global Plasma Derived Therapies Sales Market Share by Region
8.2 Global Plasma Derived Therapies Market Size by Region
8.2.1 Global Plasma Derived Therapies Market Size by Region
8.2.2 Global Plasma Derived Therapies Market Size Market Share by Region
8.3 North America
8.3.1 North America Plasma Derived Therapies Sales by Country
8.3.2 North America Plasma Derived Therapies Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Plasma Derived Therapies Sales by Country
8.4.2 Europe Plasma Derived Therapies Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Plasma Derived Therapies Sales by Region
8.5.2 Asia Pacific Plasma Derived Therapies Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Plasma Derived Therapies Sales by Country
8.6.2 South America Plasma Derived Therapies Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Plasma Derived Therapies Sales by Region
8.7.2 Middle East and Africa Plasma Derived Therapies Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 PLASMA DERIVED THERAPIES MARKET PRODUCTION BY REGION
9.1 Global Production of Plasma Derived Therapies by Region(2020-2025)
9.2 Global Plasma Derived Therapies Revenue Market Share by Region (2020-2025)
9.3 Global Plasma Derived Therapies Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Plasma Derived Therapies Production
9.4.1 North America Plasma Derived Therapies Production Growth Rate (2020-2025)
9.4.2 North America Plasma Derived Therapies Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Plasma Derived Therapies Production
9.5.1 Europe Plasma Derived Therapies Production Growth Rate (2020-2025)
9.5.2 Europe Plasma Derived Therapies Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Plasma Derived Therapies Production (2020-2025)
9.6.1 Japan Plasma Derived Therapies Production Growth Rate (2020-2025)
9.6.2 Japan Plasma Derived Therapies Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Plasma Derived Therapies Production (2020-2025)
9.7.1 China Plasma Derived Therapies Production Growth Rate (2020-2025)
9.7.2 China Plasma Derived Therapies Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 CSL Behring LLC
10.1.1 CSL Behring LLC Basic Information
10.1.2 CSL Behring LLC Plasma Derived Therapies Product Overview
10.1.3 CSL Behring LLC Plasma Derived Therapies Product Market Performance
10.1.4 CSL Behring LLC Business Overview
10.1.5 CSL Behring LLC SWOT Analysis
10.1.6 CSL Behring LLC Recent Developments
10.2 Shire
10.2.1 Shire Basic Information
10.2.2 Shire Plasma Derived Therapies Product Overview
10.2.3 Shire Plasma Derived Therapies Product Market Performance
10.2.4 Shire Business Overview
10.2.5 Shire SWOT Analysis
10.2.6 Shire Recent Developments
10.3 Bayer
10.3.1 Bayer Basic Information
10.3.2 Bayer Plasma Derived Therapies Product Overview
10.3.3 Bayer Plasma Derived Therapies Product Market Performance
10.3.4 Bayer Business Overview
10.3.5 Bayer SWOT Analysis
10.3.6 Bayer Recent Developments
10.4 Kedrion
10.4.1 Kedrion Basic Information
10.4.2 Kedrion Plasma Derived Therapies Product Overview
10.4.3 Kedrion Plasma Derived Therapies Product Market Performance
10.4.4 Kedrion Business Overview
10.4.5 Kedrion Recent Developments
10.5 Takeda
10.5.1 Takeda Basic Information
10.5.2 Takeda Plasma Derived Therapies Product Overview
10.5.3 Takeda Plasma Derived Therapies Product Market Performance
10.5.4 Takeda Business Overview
10.5.5 Takeda Recent Developments
10.6 Biotest
10.6.1 Biotest Basic Information
10.6.2 Biotest Plasma Derived Therapies Product Overview
10.6.3 Biotest Plasma Derived Therapies Product Market Performance
10.6.4 Biotest Business Overview
10.6.5 Biotest Recent Developments
10.7 Octaparma
10.7.1 Octaparma Basic Information
10.7.2 Octaparma Plasma Derived Therapies Product Overview
10.7.3 Octaparma Plasma Derived Therapies Product Market Performance
10.7.4 Octaparma Business Overview
10.7.5 Octaparma Recent Developments
10.8 Bio Products Laboratory (BPL)
10.8.1 Bio Products Laboratory (BPL) Basic Information
10.8.2 Bio Products Laboratory (BPL) Plasma Derived Therapies Product Overview
10.8.3 Bio Products Laboratory (BPL) Plasma Derived Therapies Product Market Performance
10.8.4 Bio Products Laboratory (BPL) Business Overview
10.8.5 Bio Products Laboratory (BPL) Recent Developments
10.9 LFB
10.9.1 LFB Basic Information
10.9.2 LFB Plasma Derived Therapies Product Overview
10.9.3 LFB Plasma Derived Therapies Product Market Performance
10.9.4 LFB Business Overview
10.9.5 LFB Recent Developments
10.10 Grifols
10.10.1 Grifols Basic Information
10.10.2 Grifols Plasma Derived Therapies Product Overview
10.10.3 Grifols Plasma Derived Therapies Product Market Performance
10.10.4 Grifols Business Overview
10.10.5 Grifols Recent Developments
11 PLASMA DERIVED THERAPIES MARKET FORECAST BY REGION
11.1 Global Plasma Derived Therapies Market Size Forecast
11.2 Global Plasma Derived Therapies Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Plasma Derived Therapies Market Size Forecast by Country
11.2.3 Asia Pacific Plasma Derived Therapies Market Size Forecast by Region
11.2.4 South America Plasma Derived Therapies Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Plasma Derived Therapies by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Plasma Derived Therapies Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Plasma Derived Therapies by Type (2026-2033)
12.1.2 Global Plasma Derived Therapies Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Plasma Derived Therapies by Type (2026-2033)
12.2 Global Plasma Derived Therapies Market Forecast by Application (2026-2033)
12.2.1 Global Plasma Derived Therapies Sales (K Units) Forecast by Application
12.2.2 Global Plasma Derived Therapies Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Plasma Derived Therapies
1.2 Key Market Segments
1.2.1 Plasma Derived Therapies Segment by Type
1.2.2 Plasma Derived Therapies Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PLASMA DERIVED THERAPIES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Plasma Derived Therapies Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Plasma Derived Therapies Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PLASMA DERIVED THERAPIES MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Plasma Derived Therapies Product Life Cycle
3.3 Global Plasma Derived Therapies Sales by Manufacturers (2020-2025)
3.4 Global Plasma Derived Therapies Revenue Market Share by Manufacturers (2020-2025)
3.5 Plasma Derived Therapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Plasma Derived Therapies Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Plasma Derived Therapies Market Competitive Situation and Trends
3.8.1 Plasma Derived Therapies Market Concentration Rate
3.8.2 Global 5 and 10 Largest Plasma Derived Therapies Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 PLASMA DERIVED THERAPIES INDUSTRY CHAIN ANALYSIS
4.1 Plasma Derived Therapies Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PLASMA DERIVED THERAPIES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Plasma Derived Therapies Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Plasma Derived Therapies Market
5.7 ESG Ratings of Leading Companies
6 PLASMA DERIVED THERAPIES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Plasma Derived Therapies Sales Market Share by Type (2020-2025)
6.3 Global Plasma Derived Therapies Market Size Market Share by Type (2020-2025)
6.4 Global Plasma Derived Therapies Price by Type (2020-2025)
7 PLASMA DERIVED THERAPIES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Plasma Derived Therapies Market Sales by Application (2020-2025)
7.3 Global Plasma Derived Therapies Market Size (M USD) by Application (2020-2025)
7.4 Global Plasma Derived Therapies Sales Growth Rate by Application (2020-2025)
8 PLASMA DERIVED THERAPIES MARKET SALES BY REGION
8.1 Global Plasma Derived Therapies Sales by Region
8.1.1 Global Plasma Derived Therapies Sales by Region
8.1.2 Global Plasma Derived Therapies Sales Market Share by Region
8.2 Global Plasma Derived Therapies Market Size by Region
8.2.1 Global Plasma Derived Therapies Market Size by Region
8.2.2 Global Plasma Derived Therapies Market Size Market Share by Region
8.3 North America
8.3.1 North America Plasma Derived Therapies Sales by Country
8.3.2 North America Plasma Derived Therapies Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Plasma Derived Therapies Sales by Country
8.4.2 Europe Plasma Derived Therapies Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Plasma Derived Therapies Sales by Region
8.5.2 Asia Pacific Plasma Derived Therapies Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Plasma Derived Therapies Sales by Country
8.6.2 South America Plasma Derived Therapies Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Plasma Derived Therapies Sales by Region
8.7.2 Middle East and Africa Plasma Derived Therapies Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 PLASMA DERIVED THERAPIES MARKET PRODUCTION BY REGION
9.1 Global Production of Plasma Derived Therapies by Region(2020-2025)
9.2 Global Plasma Derived Therapies Revenue Market Share by Region (2020-2025)
9.3 Global Plasma Derived Therapies Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Plasma Derived Therapies Production
9.4.1 North America Plasma Derived Therapies Production Growth Rate (2020-2025)
9.4.2 North America Plasma Derived Therapies Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Plasma Derived Therapies Production
9.5.1 Europe Plasma Derived Therapies Production Growth Rate (2020-2025)
9.5.2 Europe Plasma Derived Therapies Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Plasma Derived Therapies Production (2020-2025)
9.6.1 Japan Plasma Derived Therapies Production Growth Rate (2020-2025)
9.6.2 Japan Plasma Derived Therapies Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Plasma Derived Therapies Production (2020-2025)
9.7.1 China Plasma Derived Therapies Production Growth Rate (2020-2025)
9.7.2 China Plasma Derived Therapies Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 CSL Behring LLC
10.1.1 CSL Behring LLC Basic Information
10.1.2 CSL Behring LLC Plasma Derived Therapies Product Overview
10.1.3 CSL Behring LLC Plasma Derived Therapies Product Market Performance
10.1.4 CSL Behring LLC Business Overview
10.1.5 CSL Behring LLC SWOT Analysis
10.1.6 CSL Behring LLC Recent Developments
10.2 Shire
10.2.1 Shire Basic Information
10.2.2 Shire Plasma Derived Therapies Product Overview
10.2.3 Shire Plasma Derived Therapies Product Market Performance
10.2.4 Shire Business Overview
10.2.5 Shire SWOT Analysis
10.2.6 Shire Recent Developments
10.3 Bayer
10.3.1 Bayer Basic Information
10.3.2 Bayer Plasma Derived Therapies Product Overview
10.3.3 Bayer Plasma Derived Therapies Product Market Performance
10.3.4 Bayer Business Overview
10.3.5 Bayer SWOT Analysis
10.3.6 Bayer Recent Developments
10.4 Kedrion
10.4.1 Kedrion Basic Information
10.4.2 Kedrion Plasma Derived Therapies Product Overview
10.4.3 Kedrion Plasma Derived Therapies Product Market Performance
10.4.4 Kedrion Business Overview
10.4.5 Kedrion Recent Developments
10.5 Takeda
10.5.1 Takeda Basic Information
10.5.2 Takeda Plasma Derived Therapies Product Overview
10.5.3 Takeda Plasma Derived Therapies Product Market Performance
10.5.4 Takeda Business Overview
10.5.5 Takeda Recent Developments
10.6 Biotest
10.6.1 Biotest Basic Information
10.6.2 Biotest Plasma Derived Therapies Product Overview
10.6.3 Biotest Plasma Derived Therapies Product Market Performance
10.6.4 Biotest Business Overview
10.6.5 Biotest Recent Developments
10.7 Octaparma
10.7.1 Octaparma Basic Information
10.7.2 Octaparma Plasma Derived Therapies Product Overview
10.7.3 Octaparma Plasma Derived Therapies Product Market Performance
10.7.4 Octaparma Business Overview
10.7.5 Octaparma Recent Developments
10.8 Bio Products Laboratory (BPL)
10.8.1 Bio Products Laboratory (BPL) Basic Information
10.8.2 Bio Products Laboratory (BPL) Plasma Derived Therapies Product Overview
10.8.3 Bio Products Laboratory (BPL) Plasma Derived Therapies Product Market Performance
10.8.4 Bio Products Laboratory (BPL) Business Overview
10.8.5 Bio Products Laboratory (BPL) Recent Developments
10.9 LFB
10.9.1 LFB Basic Information
10.9.2 LFB Plasma Derived Therapies Product Overview
10.9.3 LFB Plasma Derived Therapies Product Market Performance
10.9.4 LFB Business Overview
10.9.5 LFB Recent Developments
10.10 Grifols
10.10.1 Grifols Basic Information
10.10.2 Grifols Plasma Derived Therapies Product Overview
10.10.3 Grifols Plasma Derived Therapies Product Market Performance
10.10.4 Grifols Business Overview
10.10.5 Grifols Recent Developments
11 PLASMA DERIVED THERAPIES MARKET FORECAST BY REGION
11.1 Global Plasma Derived Therapies Market Size Forecast
11.2 Global Plasma Derived Therapies Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Plasma Derived Therapies Market Size Forecast by Country
11.2.3 Asia Pacific Plasma Derived Therapies Market Size Forecast by Region
11.2.4 South America Plasma Derived Therapies Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Plasma Derived Therapies by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Plasma Derived Therapies Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Plasma Derived Therapies by Type (2026-2033)
12.1.2 Global Plasma Derived Therapies Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Plasma Derived Therapies by Type (2026-2033)
12.2 Global Plasma Derived Therapies Market Forecast by Application (2026-2033)
12.2.1 Global Plasma Derived Therapies Sales (K Units) Forecast by Application
12.2.2 Global Plasma Derived Therapies Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Plasma Derived Therapies Market Size Comparison by Region (M USD)
Table 5. Global Plasma Derived Therapies Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Plasma Derived Therapies Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Plasma Derived Therapies Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Plasma Derived Therapies Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma Derived Therapies as of 2024)
Table 10. Global Market Plasma Derived Therapies Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Plasma Derived Therapies Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Plasma Derived Therapies Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Plasma Derived Therapies Sales by Type (K Units)
Table 26. Global Plasma Derived Therapies Market Size by Type (M USD)
Table 27. Global Plasma Derived Therapies Sales (K Units) by Type (2020-2025)
Table 28. Global Plasma Derived Therapies Sales Market Share by Type (2020-2025)
Table 29. Global Plasma Derived Therapies Market Size (M USD) by Type (2020-2025)
Table 30. Global Plasma Derived Therapies Market Size Share by Type (2020-2025)
Table 31. Global Plasma Derived Therapies Price (USD/Unit) by Type (2020-2025)
Table 32. Global Plasma Derived Therapies Sales (K Units) by Application
Table 33. Global Plasma Derived Therapies Market Size by Application
Table 34. Global Plasma Derived Therapies Sales by Application (2020-2025) & (K Units)
Table 35. Global Plasma Derived Therapies Sales Market Share by Application (2020-2025)
Table 36. Global Plasma Derived Therapies Market Size by Application (2020-2025) & (M USD)
Table 37. Global Plasma Derived Therapies Market Share by Application (2020-2025)
Table 38. Global Plasma Derived Therapies Sales Growth Rate by Application (2020-2025)
Table 39. Global Plasma Derived Therapies Sales by Region (2020-2025) & (K Units)
Table 40. Global Plasma Derived Therapies Sales Market Share by Region (2020-2025)
Table 41. Global Plasma Derived Therapies Market Size by Region (2020-2025) & (M USD)
Table 42. Global Plasma Derived Therapies Market Size Market Share by Region (2020-2025)
Table 43. North America Plasma Derived Therapies Sales by Country (2020-2025) & (K Units)
Table 44. North America Plasma Derived Therapies Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Plasma Derived Therapies Sales by Country (2020-2025) & (K Units)
Table 46. Europe Plasma Derived Therapies Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Plasma Derived Therapies Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific Plasma Derived Therapies Market Size by Region (2020-2025) & (M USD)
Table 49. South America Plasma Derived Therapies Sales by Country (2020-2025) & (K Units)
Table 50. South America Plasma Derived Therapies Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Plasma Derived Therapies Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa Plasma Derived Therapies Market Size by Region (2020-2025) & (M USD)
Table 53. Global Plasma Derived Therapies Production (K Units) by Region(2020-2025)
Table 54. Global Plasma Derived Therapies Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Plasma Derived Therapies Revenue Market Share by Region (2020-2025)
Table 56. Global Plasma Derived Therapies Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America Plasma Derived Therapies Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe Plasma Derived Therapies Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan Plasma Derived Therapies Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China Plasma Derived Therapies Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. CSL Behring LLC Basic Information
Table 62. CSL Behring LLC Plasma Derived Therapies Product Overview
Table 63. CSL Behring LLC Plasma Derived Therapies Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. CSL Behring LLC Business Overview
Table 65. CSL Behring LLC SWOT Analysis
Table 66. CSL Behring LLC Recent Developments
Table 67. Shire Basic Information
Table 68. Shire Plasma Derived Therapies Product Overview
Table 69. Shire Plasma Derived Therapies Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. Shire Business Overview
Table 71. Shire SWOT Analysis
Table 72. Shire Recent Developments
Table 73. Bayer Basic Information
Table 74. Bayer Plasma Derived Therapies Product Overview
Table 75. Bayer Plasma Derived Therapies Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Bayer Business Overview
Table 77. Bayer SWOT Analysis
Table 78. Bayer Recent Developments
Table 79. Kedrion Basic Information
Table 80. Kedrion Plasma Derived Therapies Product Overview
Table 81. Kedrion Plasma Derived Therapies Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Kedrion Business Overview
Table 83. Kedrion Recent Developments
Table 84. Takeda Basic Information
Table 85. Takeda Plasma Derived Therapies Product Overview
Table 86. Takeda Plasma Derived Therapies Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Takeda Business Overview
Table 88. Takeda Recent Developments
Table 89. Biotest Basic Information
Table 90. Biotest Plasma Derived Therapies Product Overview
Table 91. Biotest Plasma Derived Therapies Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Biotest Business Overview
Table 93. Biotest Recent Developments
Table 94. Octaparma Basic Information
Table 95. Octaparma Plasma Derived Therapies Product Overview
Table 96. Octaparma Plasma Derived Therapies Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Octaparma Business Overview
Table 98. Octaparma Recent Developments
Table 99. Bio Products Laboratory (BPL) Basic Information
Table 100. Bio Products Laboratory (BPL) Plasma Derived Therapies Product Overview
Table 101. Bio Products Laboratory (BPL) Plasma Derived Therapies Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Bio Products Laboratory (BPL) Business Overview
Table 103. Bio Products Laboratory (BPL) Recent Developments
Table 104. LFB Basic Information
Table 105. LFB Plasma Derived Therapies Product Overview
Table 106. LFB Plasma Derived Therapies Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. LFB Business Overview
Table 108. LFB Recent Developments
Table 109. Grifols Basic Information
Table 110. Grifols Plasma Derived Therapies Product Overview
Table 111. Grifols Plasma Derived Therapies Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Grifols Business Overview
Table 113. Grifols Recent Developments
Table 114. Global Plasma Derived Therapies Sales Forecast by Region (2026-2033) & (K Units)
Table 115. Global Plasma Derived Therapies Market Size Forecast by Region (2026-2033) & (M USD)
Table 116. North America Plasma Derived Therapies Sales Forecast by Country (2026-2033) & (K Units)
Table 117. North America Plasma Derived Therapies Market Size Forecast by Country (2026-2033) & (M USD)
Table 118. Europe Plasma Derived Therapies Sales Forecast by Country (2026-2033) & (K Units)
Table 119. Europe Plasma Derived Therapies Market Size Forecast by Country (2026-2033) & (M USD)
Table 120. Asia Pacific Plasma Derived Therapies Sales Forecast by Region (2026-2033) & (K Units)
Table 121. Asia Pacific Plasma Derived Therapies Market Size Forecast by Region (2026-2033) & (M USD)
Table 122. South America Plasma Derived Therapies Sales Forecast by Country (2026-2033) & (K Units)
Table 123. South America Plasma Derived Therapies Market Size Forecast by Country (2026-2033) & (M USD)
Table 124. Middle East and Africa Plasma Derived Therapies Sales Forecast by Country (2026-2033) & (Units)
Table 125. Middle East and Africa Plasma Derived Therapies Market Size Forecast by Country (2026-2033) & (M USD)
Table 126. Global Plasma Derived Therapies Sales Forecast by Type (2026-2033) & (K Units)
Table 127. Global Plasma Derived Therapies Market Size Forecast by Type (2026-2033) & (M USD)
Table 128. Global Plasma Derived Therapies Price Forecast by Type (2026-2033) & (USD/Unit)
Table 129. Global Plasma Derived Therapies Sales (K Units) Forecast by Application (2026-2033)
Table 130. Global Plasma Derived Therapies Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Plasma Derived Therapies Market Size Comparison by Region (M USD)
Table 5. Global Plasma Derived Therapies Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Plasma Derived Therapies Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Plasma Derived Therapies Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Plasma Derived Therapies Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma Derived Therapies as of 2024)
Table 10. Global Market Plasma Derived Therapies Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Plasma Derived Therapies Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Plasma Derived Therapies Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Plasma Derived Therapies Sales by Type (K Units)
Table 26. Global Plasma Derived Therapies Market Size by Type (M USD)
Table 27. Global Plasma Derived Therapies Sales (K Units) by Type (2020-2025)
Table 28. Global Plasma Derived Therapies Sales Market Share by Type (2020-2025)
Table 29. Global Plasma Derived Therapies Market Size (M USD) by Type (2020-2025)
Table 30. Global Plasma Derived Therapies Market Size Share by Type (2020-2025)
Table 31. Global Plasma Derived Therapies Price (USD/Unit) by Type (2020-2025)
Table 32. Global Plasma Derived Therapies Sales (K Units) by Application
Table 33. Global Plasma Derived Therapies Market Size by Application
Table 34. Global Plasma Derived Therapies Sales by Application (2020-2025) & (K Units)
Table 35. Global Plasma Derived Therapies Sales Market Share by Application (2020-2025)
Table 36. Global Plasma Derived Therapies Market Size by Application (2020-2025) & (M USD)
Table 37. Global Plasma Derived Therapies Market Share by Application (2020-2025)
Table 38. Global Plasma Derived Therapies Sales Growth Rate by Application (2020-2025)
Table 39. Global Plasma Derived Therapies Sales by Region (2020-2025) & (K Units)
Table 40. Global Plasma Derived Therapies Sales Market Share by Region (2020-2025)
Table 41. Global Plasma Derived Therapies Market Size by Region (2020-2025) & (M USD)
Table 42. Global Plasma Derived Therapies Market Size Market Share by Region (2020-2025)
Table 43. North America Plasma Derived Therapies Sales by Country (2020-2025) & (K Units)
Table 44. North America Plasma Derived Therapies Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Plasma Derived Therapies Sales by Country (2020-2025) & (K Units)
Table 46. Europe Plasma Derived Therapies Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Plasma Derived Therapies Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific Plasma Derived Therapies Market Size by Region (2020-2025) & (M USD)
Table 49. South America Plasma Derived Therapies Sales by Country (2020-2025) & (K Units)
Table 50. South America Plasma Derived Therapies Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Plasma Derived Therapies Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa Plasma Derived Therapies Market Size by Region (2020-2025) & (M USD)
Table 53. Global Plasma Derived Therapies Production (K Units) by Region(2020-2025)
Table 54. Global Plasma Derived Therapies Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Plasma Derived Therapies Revenue Market Share by Region (2020-2025)
Table 56. Global Plasma Derived Therapies Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America Plasma Derived Therapies Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe Plasma Derived Therapies Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan Plasma Derived Therapies Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China Plasma Derived Therapies Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. CSL Behring LLC Basic Information
Table 62. CSL Behring LLC Plasma Derived Therapies Product Overview
Table 63. CSL Behring LLC Plasma Derived Therapies Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. CSL Behring LLC Business Overview
Table 65. CSL Behring LLC SWOT Analysis
Table 66. CSL Behring LLC Recent Developments
Table 67. Shire Basic Information
Table 68. Shire Plasma Derived Therapies Product Overview
Table 69. Shire Plasma Derived Therapies Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. Shire Business Overview
Table 71. Shire SWOT Analysis
Table 72. Shire Recent Developments
Table 73. Bayer Basic Information
Table 74. Bayer Plasma Derived Therapies Product Overview
Table 75. Bayer Plasma Derived Therapies Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Bayer Business Overview
Table 77. Bayer SWOT Analysis
Table 78. Bayer Recent Developments
Table 79. Kedrion Basic Information
Table 80. Kedrion Plasma Derived Therapies Product Overview
Table 81. Kedrion Plasma Derived Therapies Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Kedrion Business Overview
Table 83. Kedrion Recent Developments
Table 84. Takeda Basic Information
Table 85. Takeda Plasma Derived Therapies Product Overview
Table 86. Takeda Plasma Derived Therapies Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Takeda Business Overview
Table 88. Takeda Recent Developments
Table 89. Biotest Basic Information
Table 90. Biotest Plasma Derived Therapies Product Overview
Table 91. Biotest Plasma Derived Therapies Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Biotest Business Overview
Table 93. Biotest Recent Developments
Table 94. Octaparma Basic Information
Table 95. Octaparma Plasma Derived Therapies Product Overview
Table 96. Octaparma Plasma Derived Therapies Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Octaparma Business Overview
Table 98. Octaparma Recent Developments
Table 99. Bio Products Laboratory (BPL) Basic Information
Table 100. Bio Products Laboratory (BPL) Plasma Derived Therapies Product Overview
Table 101. Bio Products Laboratory (BPL) Plasma Derived Therapies Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Bio Products Laboratory (BPL) Business Overview
Table 103. Bio Products Laboratory (BPL) Recent Developments
Table 104. LFB Basic Information
Table 105. LFB Plasma Derived Therapies Product Overview
Table 106. LFB Plasma Derived Therapies Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. LFB Business Overview
Table 108. LFB Recent Developments
Table 109. Grifols Basic Information
Table 110. Grifols Plasma Derived Therapies Product Overview
Table 111. Grifols Plasma Derived Therapies Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Grifols Business Overview
Table 113. Grifols Recent Developments
Table 114. Global Plasma Derived Therapies Sales Forecast by Region (2026-2033) & (K Units)
Table 115. Global Plasma Derived Therapies Market Size Forecast by Region (2026-2033) & (M USD)
Table 116. North America Plasma Derived Therapies Sales Forecast by Country (2026-2033) & (K Units)
Table 117. North America Plasma Derived Therapies Market Size Forecast by Country (2026-2033) & (M USD)
Table 118. Europe Plasma Derived Therapies Sales Forecast by Country (2026-2033) & (K Units)
Table 119. Europe Plasma Derived Therapies Market Size Forecast by Country (2026-2033) & (M USD)
Table 120. Asia Pacific Plasma Derived Therapies Sales Forecast by Region (2026-2033) & (K Units)
Table 121. Asia Pacific Plasma Derived Therapies Market Size Forecast by Region (2026-2033) & (M USD)
Table 122. South America Plasma Derived Therapies Sales Forecast by Country (2026-2033) & (K Units)
Table 123. South America Plasma Derived Therapies Market Size Forecast by Country (2026-2033) & (M USD)
Table 124. Middle East and Africa Plasma Derived Therapies Sales Forecast by Country (2026-2033) & (Units)
Table 125. Middle East and Africa Plasma Derived Therapies Market Size Forecast by Country (2026-2033) & (M USD)
Table 126. Global Plasma Derived Therapies Sales Forecast by Type (2026-2033) & (K Units)
Table 127. Global Plasma Derived Therapies Market Size Forecast by Type (2026-2033) & (M USD)
Table 128. Global Plasma Derived Therapies Price Forecast by Type (2026-2033) & (USD/Unit)
Table 129. Global Plasma Derived Therapies Sales (K Units) Forecast by Application (2026-2033)
Table 130. Global Plasma Derived Therapies Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Plasma Derived Therapies
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Plasma Derived Therapies Market Size (M USD), 2024-2033
Figure 5. Global Plasma Derived Therapies Market Size (M USD) (2020-2033)
Figure 6. Global Plasma Derived Therapies Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Plasma Derived Therapies Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Plasma Derived Therapies Product Life Cycle
Figure 13. Plasma Derived Therapies Sales Share by Manufacturers in 2024
Figure 14. Global Plasma Derived Therapies Revenue Share by Manufacturers in 2024
Figure 15. Plasma Derived Therapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Plasma Derived Therapies Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Plasma Derived Therapies Revenue in 2024
Figure 18. Industry Chain Map of Plasma Derived Therapies
Figure 19. Global Plasma Derived Therapies Market PEST Analysis
Figure 20. Global Plasma Derived Therapies Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Plasma Derived Therapies Market Share by Type
Figure 27. Sales Market Share of Plasma Derived Therapies by Type (2020-2025)
Figure 28. Sales Market Share of Plasma Derived Therapies by Type in 2024
Figure 29. Market Size Share of Plasma Derived Therapies by Type (2020-2025)
Figure 30. Market Size Share of Plasma Derived Therapies by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Plasma Derived Therapies Market Share by Application
Figure 33. Global Plasma Derived Therapies Sales Market Share by Application (2020-2025)
Figure 34. Global Plasma Derived Therapies Sales Market Share by Application in 2024
Figure 35. Global Plasma Derived Therapies Market Share by Application (2020-2025)
Figure 36. Global Plasma Derived Therapies Market Share by Application in 2024
Figure 37. Global Plasma Derived Therapies Sales Growth Rate by Application (2020-2025)
Figure 38. Global Plasma Derived Therapies Sales Market Share by Region (2020-2025)
Figure 39. Global Plasma Derived Therapies Market Size Market Share by Region (2020-2025)
Figure 40. North America Plasma Derived Therapies Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Plasma Derived Therapies Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Plasma Derived Therapies Sales Market Share by Country in 2024
Figure 43. North America Plasma Derived Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Plasma Derived Therapies Market Size Market Share by Country in 2024
Figure 45. U.S. Plasma Derived Therapies Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Plasma Derived Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Plasma Derived Therapies Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Plasma Derived Therapies Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Plasma Derived Therapies Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Plasma Derived Therapies Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Plasma Derived Therapies Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Plasma Derived Therapies Sales Market Share by Country in 2024
Figure 53. Europe Plasma Derived Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Plasma Derived Therapies Market Size Market Share by Country in 2024
Figure 55. Germany Plasma Derived Therapies Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Plasma Derived Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Plasma Derived Therapies Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Plasma Derived Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Plasma Derived Therapies Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Plasma Derived Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Plasma Derived Therapies Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Plasma Derived Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Plasma Derived Therapies Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Plasma Derived Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Plasma Derived Therapies Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Plasma Derived Therapies Sales Market Share by Region in 2024
Figure 67. Asia Pacific Plasma Derived Therapies Market Size Market Share by Region in 2024
Figure 68. China Plasma Derived Therapies Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Plasma Derived Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Plasma Derived Therapies Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Plasma Derived Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Plasma Derived Therapies Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Plasma Derived Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Plasma Derived Therapies Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Plasma Derived Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Plasma Derived Therapies Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Plasma Derived Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Plasma Derived Therapies Sales and Growth Rate (K Units)
Figure 79. South America Plasma Derived Therapies Sales Market Share by Country in 2024
Figure 80. South America Plasma Derived Therapies Market Size and Growth Rate (M USD)
Figure 81. South America Plasma Derived Therapies Market Size Market Share by Country in 2024
Figure 82. Brazil Plasma Derived Therapies Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Plasma Derived Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Plasma Derived Therapies Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Plasma Derived Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Plasma Derived Therapies Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Plasma Derived Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Plasma Derived Therapies Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Plasma Derived Therapies Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Plasma Derived Therapies Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Plasma Derived Therapies Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Plasma Derived Therapies Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Plasma Derived Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Plasma Derived Therapies Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Plasma Derived Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Plasma Derived Therapies Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Plasma Derived Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Plasma Derived Therapies Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Plasma Derived Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Plasma Derived Therapies Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Plasma Derived Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Plasma Derived Therapies Production Market Share by Region (2020-2025)
Figure 103. North America Plasma Derived Therapies Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Plasma Derived Therapies Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Plasma Derived Therapies Production (K Units) Growth Rate (2020-2025)
Figure 106. China Plasma Derived Therapies Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Plasma Derived Therapies Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Plasma Derived Therapies Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Plasma Derived Therapies Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Plasma Derived Therapies Market Share Forecast by Type (2026-2033)
Figure 111. Global Plasma Derived Therapies Sales Forecast by Application (2026-2033)
Figure 112. Global Plasma Derived Therapies Market Share Forecast by Application (2026-2033)
Figure 1. Product Picture of Plasma Derived Therapies
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Plasma Derived Therapies Market Size (M USD), 2024-2033
Figure 5. Global Plasma Derived Therapies Market Size (M USD) (2020-2033)
Figure 6. Global Plasma Derived Therapies Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Plasma Derived Therapies Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Plasma Derived Therapies Product Life Cycle
Figure 13. Plasma Derived Therapies Sales Share by Manufacturers in 2024
Figure 14. Global Plasma Derived Therapies Revenue Share by Manufacturers in 2024
Figure 15. Plasma Derived Therapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Plasma Derived Therapies Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Plasma Derived Therapies Revenue in 2024
Figure 18. Industry Chain Map of Plasma Derived Therapies
Figure 19. Global Plasma Derived Therapies Market PEST Analysis
Figure 20. Global Plasma Derived Therapies Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Plasma Derived Therapies Market Share by Type
Figure 27. Sales Market Share of Plasma Derived Therapies by Type (2020-2025)
Figure 28. Sales Market Share of Plasma Derived Therapies by Type in 2024
Figure 29. Market Size Share of Plasma Derived Therapies by Type (2020-2025)
Figure 30. Market Size Share of Plasma Derived Therapies by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Plasma Derived Therapies Market Share by Application
Figure 33. Global Plasma Derived Therapies Sales Market Share by Application (2020-2025)
Figure 34. Global Plasma Derived Therapies Sales Market Share by Application in 2024
Figure 35. Global Plasma Derived Therapies Market Share by Application (2020-2025)
Figure 36. Global Plasma Derived Therapies Market Share by Application in 2024
Figure 37. Global Plasma Derived Therapies Sales Growth Rate by Application (2020-2025)
Figure 38. Global Plasma Derived Therapies Sales Market Share by Region (2020-2025)
Figure 39. Global Plasma Derived Therapies Market Size Market Share by Region (2020-2025)
Figure 40. North America Plasma Derived Therapies Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Plasma Derived Therapies Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Plasma Derived Therapies Sales Market Share by Country in 2024
Figure 43. North America Plasma Derived Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Plasma Derived Therapies Market Size Market Share by Country in 2024
Figure 45. U.S. Plasma Derived Therapies Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Plasma Derived Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Plasma Derived Therapies Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Plasma Derived Therapies Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Plasma Derived Therapies Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Plasma Derived Therapies Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Plasma Derived Therapies Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Plasma Derived Therapies Sales Market Share by Country in 2024
Figure 53. Europe Plasma Derived Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Plasma Derived Therapies Market Size Market Share by Country in 2024
Figure 55. Germany Plasma Derived Therapies Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Plasma Derived Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Plasma Derived Therapies Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Plasma Derived Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Plasma Derived Therapies Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Plasma Derived Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Plasma Derived Therapies Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Plasma Derived Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Plasma Derived Therapies Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Plasma Derived Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Plasma Derived Therapies Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Plasma Derived Therapies Sales Market Share by Region in 2024
Figure 67. Asia Pacific Plasma Derived Therapies Market Size Market Share by Region in 2024
Figure 68. China Plasma Derived Therapies Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Plasma Derived Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Plasma Derived Therapies Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Plasma Derived Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Plasma Derived Therapies Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Plasma Derived Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Plasma Derived Therapies Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Plasma Derived Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Plasma Derived Therapies Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Plasma Derived Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Plasma Derived Therapies Sales and Growth Rate (K Units)
Figure 79. South America Plasma Derived Therapies Sales Market Share by Country in 2024
Figure 80. South America Plasma Derived Therapies Market Size and Growth Rate (M USD)
Figure 81. South America Plasma Derived Therapies Market Size Market Share by Country in 2024
Figure 82. Brazil Plasma Derived Therapies Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Plasma Derived Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Plasma Derived Therapies Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Plasma Derived Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Plasma Derived Therapies Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Plasma Derived Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Plasma Derived Therapies Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Plasma Derived Therapies Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Plasma Derived Therapies Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Plasma Derived Therapies Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Plasma Derived Therapies Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Plasma Derived Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Plasma Derived Therapies Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Plasma Derived Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Plasma Derived Therapies Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Plasma Derived Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Plasma Derived Therapies Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Plasma Derived Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Plasma Derived Therapies Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Plasma Derived Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Plasma Derived Therapies Production Market Share by Region (2020-2025)
Figure 103. North America Plasma Derived Therapies Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Plasma Derived Therapies Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Plasma Derived Therapies Production (K Units) Growth Rate (2020-2025)
Figure 106. China Plasma Derived Therapies Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Plasma Derived Therapies Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Plasma Derived Therapies Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Plasma Derived Therapies Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Plasma Derived Therapies Market Share Forecast by Type (2026-2033)
Figure 111. Global Plasma Derived Therapies Sales Forecast by Application (2026-2033)
Figure 112. Global Plasma Derived Therapies Market Share Forecast by Application (2026-2033)
